Abstract:
Objective This study aims to investigate the correlation between the expression of FoxP3, TGF-β1, and epithelial-mesenchymal transition (EMT) in breast cancer and to determine the clinical significance of FoxP3.
Methods The expression of FoxP3, TGF-β1, E-Cadherin, N-Cadherin, Vimentin, and Fibronectin protein were detected in the cancer cells of 74 cases with breast carcinoma via immunohistochemistry.The correlation of FoxP3 protein with clinico-pathologic features of breast carcinoma and the relationships among the expressions of FoxP3, TGF-β1, and epithelial-mesenchymal transition (EMT) were analyzed.
Results The expression rates of FoxP3, TGF-β1, and EMT are 36.5%(27/74), 39.2%(29/74), and 40.5%(30/74), respectively.The FoxP3 protein expression in breast cancer is correlated with lymph node metastasis (P < 0.05) but not with other clinico-pathological features (P>0.05). The expression of FoxP3 is also correlated with the expression of TGF-β1.Furthermore, TGF-β1 can induce EMT (P < 0.05).
Conclusion The expression of FoxP3 is correlated with lymph node metastasis and EMT in breast cancer.Therefore, FoxP3 may be a marker for predicting metastasis.